1. Home
  2. GANX vs SUNS Comparison

GANX vs SUNS Comparison

Compare GANX & SUNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gain Therapeutics Inc.

GANX

Gain Therapeutics Inc.

HOLD

Current Price

$3.98

Market Cap

159.2M

Sector

Health Care

ML Signal

HOLD

Logo Sunrise Realty Trust Inc.

SUNS

Sunrise Realty Trust Inc.

HOLD

Current Price

$10.17

Market Cap

128.7M

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
GANX
SUNS
Founded
2017
2023
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
159.2M
128.7M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
GANX
SUNS
Price
$3.98
$10.17
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
6
3
Target Price
$8.00
$13.50
AVG Volume (30 Days)
1.2M
89.8K
Earning Date
11-12-2025
11-13-2025
Dividend Yield
N/A
11.67%
EPS Growth
N/A
1112.46
EPS
N/A
1.09
Revenue
N/A
$19,384,703.00
Revenue This Year
N/A
$174.58
Revenue Next Year
N/A
$60.45
P/E Ratio
N/A
$9.42
Revenue Growth
N/A
2540.16
52 Week Low
$1.41
$7.80
52 Week High
$4.34
$14.87

Technical Indicators

Market Signals
Indicator
GANX
SUNS
Relative Strength Index (RSI) 69.52 56.34
Support Level $3.94 $10.04
Resistance Level $4.34 $10.38
Average True Range (ATR) 0.38 0.34
MACD 0.04 0.05
Stochastic Oscillator 77.78 75.48

Price Performance

Historical Comparison
GANX
SUNS

About GANX Gain Therapeutics Inc.

Gain Therapeutics Inc is a biotechnology company developing novel small molecule therapeutics to treat diseases across several therapeutic areas, including, lysosomal storage disorders, central nervous system disorders, metabolic disorders, and oncology. The company's clinical-stage product candidate, GT-02287, is being developed for the treatment of GBA1 Parkinson's disease. The company uses its computational target and drug discovery platform, Magellan, to discover novel allosteric binding sites on proteins implicated in disease and to identify proprietary small molecules that bind these sites to modulate protein function and treat the underlying cause of the disease. Geographically, the company operates in Switzerland, Spain, the United States, and Australia.

About SUNS Sunrise Realty Trust Inc.

Sunrise Realty Trust Inc is a real estate investment trust company. It is focus on originating CRE debt investments and providing capital to high-quality borrowers and sponsors with transitional business plans collateralized by CRE assets with opportunities for near-term value creation, as well as recapitalization opportunities. It intends to create a diversified investment portfolio, targeting investments in senior mortgage loans, mezzanine loans, whole loans, B-notes, CMBS and debt-like preferred equity securities across CRE asset classes and investment mix to include high quality multi-family, condominiums, retail, office, hospitality, industrial, mixed use and specialty-use real estate.

Share on Social Networks: